NCT03655197View on ClinicalTrials.gov

Lipidome and Microbiome Profile of the Eye in Rosacea

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

June 30, 2021

Study Completion Date

July 1, 2021

Conditions
RosaceaOcular RosaceaCutaneous Rosacea
Interventions
DRUG

Doxycycline

For those participating in the Doxycycline intervention, they will take 100 mg twice daily for 1 month.

Trial Locations (1)

95816

University of California-Davis, Department of Dermatology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT03655197 - Lipidome and Microbiome Profile of the Eye in Rosacea | Biotech Hunter | Biotech Hunter